BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 6955994)

  • 1. HLA-A, B, C, DR antigens, Bf, C4 and glyoxalase I (GLO) polymorphisms in French Basques with insulin-dependent diabetes mellitus (IDDM).
    Cambon-de Mouzon A; Ohayon E; Hauptmann G; Sevin A; Abbal M; Sommer E; Vergnes H; Ducos J
    Tissue Antigens; 1982 May; 19(5):366-79. PubMed ID: 6955994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human MHC class III (Bf, C2, C4) genes and GLO: their association with other HLA antigens and extended haplotypes in the Spanish population.
    Regueiro JR; Arnaiz-Villena A
    Tissue Antigens; 1988 Jan; 31(1):14-25. PubMed ID: 3341017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic heterogeneity of insulin-dependent (type I) diabetes mellitus: evidence from a study of extended haplotypes.
    Rich SS; Weitkamp LR; Barbosa J
    Am J Hum Genet; 1984 Sep; 36(5):1015-23. PubMed ID: 6594040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of HLA, factor B (Bf), complement C2 and C4 haplotypes in type 1 diabetic and control families from northern Sweden.
    Hägglöf B; Holmgren G; Holmlund G; Lindblom B; Olaisen B; Teisberg P
    Hum Hered; 1986; 36(4):201-12. PubMed ID: 3639057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA and GM in insulin-dependent diabetes in the Netherlands: report on a combined multiplex family and population study.
    de Jongh BM; Bruining GJ; Schreuder GM; Schuurman RK; Radder JK; van Loghem E; Meera Khan P; Hauptmann G; van Rood JJ
    Hum Immunol; 1984 May; 10(1):5-21. PubMed ID: 6586708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linkage of GLO with HLA in a sample of the Spanish population.
    Lopez-Larrea C; Bootello A; Arnaiz-Villena A
    Hum Genet; 1981; 57(3):317-20. PubMed ID: 6941923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HLA system in the Korean population.
    Kim SJ; Nisperos B; Mickelson E; Choi IH; Dahlberg S; Kim JD; Giblett ER; Hansen JA
    Hum Immunol; 1986 Nov; 17(3):259-72. PubMed ID: 3793531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Polymorphism of C4 and factor B in type I diabetes].
    Blickle JF; Hauptmann G; Goetz J; Tongio MM; Mayer S; Brogard JM; Dorner M
    Pathol Biol (Paris); 1988 Jun; 36(6):791-4. PubMed ID: 3047638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of cis and trans interactions between extended HLA-haplotypes in insulin-dependent diabetes.
    Deschamps I; Marcelli-Barge A; Lallemand N; Poirier JC; Bochu V; Prévost P; Busson A; Massét M; Lestradet H; Hors J
    Tissue Antigens; 1988 May; 31(5):259-69. PubMed ID: 3400091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility to IDDM is marked by MHC supratypes rather than individual alleles.
    Kelly H; McCann VJ; Kay PH; Dawkins RL
    Immunogenetics; 1985; 22(6):643-51. PubMed ID: 3865895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properdin factor B (Bf) and glyoxalase in Graves' disease.
    Allannic H; Fauchet R; Lorcy Y; Phengsavath H; Gueguen M; Knoi TD; Genetet B; Le Gall JY
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):57-61. PubMed ID: 6572032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement and HLA. Further definition of high-risk haplotypes in insulin-dependent diabetes.
    Rich S; O'Neill G; Dalmasso AP; Nerl C; Barbosa J
    Diabetes; 1985 May; 34(5):504-9. PubMed ID: 3987976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor B (Bf) and glyoxalase genes in insulin-dependent diabetes mellitus.
    Allannic H; Fauchet R; Gueguen M; Pheng Savath H; Dinh Knoi T; Genetet B
    Diabete Metab; 1985 Feb; 11(1):22-6. PubMed ID: 3856541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complotype genetic loci segregate more frequently with HLA-DR than with HLA-B.
    Yunis EJ; Awdeh Z; Johnson A; Suciu-Foca N; Robinson MA; Hartzman R; Raum D; Fleischnick E; Alper CA
    Immunogenetics; 1985; 21(1):25-31. PubMed ID: 3871424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA antigens in insulin dependent and non-insulin dependent Spanish diabetic patients.
    Serrano-Ríos M; Regueiro JR; Severino R; López-Larrea C; Arnaiz-Villena A
    Diabete Metab; 1983; 9(2):116-20. PubMed ID: 6352349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genetic susceptibility to type 1 (insulin-dependent) diabetes: analysis of the HLA-DR association.
    Wolf E; Spencer KM; Cudworth AG
    Diabetologia; 1983 Apr; 24(4):224-30. PubMed ID: 6407886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-A,B,C, Bf and glyoxalase I polymorphisms in a sample of the Kabyle population (Algeria).
    Bouali M; Dehay C; Benajam A; Poirier JC; Degos L; Marcelli-Barge A
    Tissue Antigens; 1981 May; 17(5):501-6. PubMed ID: 7336415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population genetic analyses of insulin dependent diabetes mellitus using HLA allele frequencies.
    Murphy CC; Acton RT; Barger BO; Go RC; Kirk KA; Reitnauer PJ; Roseman JM
    Clin Genet; 1983 Jun; 23(6):405-14. PubMed ID: 6411398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linkage disequilibrium of HLA-SB1 with the HLA-A1, B8, DR3, SCO1 and of HLA-SB4 with the HLA-A26, Bw38, Dw10, DR4, SC21 extended haplotypes.
    Matsui Y; Alosco SM; Awdeh Z; Duquesnoy RJ; Page PL; Hartzman RJ; Alper CA; Yunis EJ
    Immunogenetics; 1984; 20(6):623-31. PubMed ID: 6239824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.